There are both positive and negative outcomes of the evolution of pharmaceuticals in the U.S. health care system. For example, Pharmacogenomics is a study of how the human genes affect the response to medications. This is a positive outcome because now we are able to test and analyze multiple genes simultaneously, rather than one at a time. The expense of medication is a negative one because patients are unable to afford drugs, due to the rising cost of drugs and insurance. Another negative outcome of the evolution of pharmaceuticals is prescription drug side effects. There has been a number of patients that have died or either suffered from prescription drugs. The side affects of these drugs are considered dangerous.
